Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications.

Kim TH, Kim MY, Jo SH, Park JM, Ahn YH.

Yonsei Med J. 2013 May 1;54(3):545-59. doi: 10.3349/ymj.2013.54.3.545. Review.

2.

Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.

Floyd ZE, Stephens JM.

Biochim Biophys Acta. 2012 Jul;1822(7):1090-5. doi: 10.1016/j.bbadis.2012.03.014. Review.

3.

G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.

Wang S, Awad KS, Elinoff JM, Dougherty EJ, Ferreyra GA, Wang JY, Cai R, Sun J, Ptasinska A, Danner RL.

J Biol Chem. 2015 Aug 7;290(32):19544-57. doi: 10.1074/jbc.M115.638924.

4.

O-GlcNAc modification of PPARγ reduces its transcriptional activity.

Ji S, Park SY, Roth J, Kim HS, Cho JW.

Biochem Biophys Res Commun. 2012 Jan 27;417(4):1158-63. doi: 10.1016/j.bbrc.2011.12.086.

PMID:
22226965
5.

Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?

Luconi M, Cantini G, Serio M.

Steroids. 2010 Aug-Sep;75(8-9):585-94. doi: 10.1016/j.steroids.2009.10.012. Review.

PMID:
19900469
6.
8.
9.

Adipose tissue and bone: role of PPARγ in adipogenesis and osteogenesis.

Kawai M.

Horm Mol Biol Clin Investig. 2013 Sep;15(3):105-13. doi: 10.1515/hmbci-2013-0036. Review.

PMID:
25436737
10.

Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.

Schopfer FJ, Cole MP, Groeger AL, Chen CS, Khoo NK, Woodcock SR, Golin-Bisello F, Motanya UN, Li Y, Zhang J, Garcia-Barrio MT, Rudolph TK, Rudolph V, Bonacci G, Baker PR, Xu HE, Batthyany CI, Chen YE, Hallis TM, Freeman BA.

J Biol Chem. 2010 Apr 16;285(16):12321-33. doi: 10.1074/jbc.M109.091512.

11.

Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis.

Voutsadakis IA.

J Cancer Res Clin Oncol. 2007 Dec;133(12):917-28. Review.

PMID:
17659359
12.

Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.

Araki O, Ying H, Furuya F, Zhu X, Cheng SY.

Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16251-6.

13.

PPARγ signaling and metabolism: the good, the bad and the future.

Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM.

Nat Med. 2013 May;19(5):557-66. doi: 10.1038/nm.3159. Review.

14.
15.

A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription.

Krätzner R, Fröhlich F, Lepler K, Schröder M, Röher K, Dickel C, Tzvetkov MV, Quentin T, Oetjen E, Knepel W.

Mol Pharmacol. 2008 Feb;73(2):509-17.

16.
17.

Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol.

Floyd ZE, Wang ZQ, Kilroy G, Cefalu WT.

Metabolism. 2008 Jul;57(7 Suppl 1):S32-8. doi: 10.1016/j.metabol.2008.04.006.

18.

PPARγ: a circadian transcription factor in adipogenesis and osteogenesis.

Kawai M, Rosen CJ.

Nat Rev Endocrinol. 2010 Nov;6(11):629-36. doi: 10.1038/nrendo.2010.155. Review.

19.

A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.

Tagami T, Yamamoto H, Moriyama K, Sawai K, Usui T, Shimatsu A, Naruse M.

Endocrinology. 2009 Feb;150(2):862-70. doi: 10.1210/en.2008-0502.

PMID:
19147680
20.

Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.

D'Argenio G, Petillo O, Margarucci S, Torpedine A, Calarco A, Koverech A, Boccia A, Paolella G, Peluso G.

J Biol Chem. 2010 Aug 27;285(35):27078-87. doi: 10.1074/jbc.M110.109678.

Supplemental Content

Support Center